EUVIMEDEUVIMED entdecken
Crossref

Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy

Sandeep, Suraj H Shinde, Sakeel Ahmed, Shyam Sunder Sharma, Abhay H Pande

Applied Biochemistry and Biotechnology · 2026-07 · 198 (7) · 5212-5230

DOI: 10.1007/s12010-026-05702-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, online erschienen am 15.04.2026. Verfasst von Sandeep und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, In…. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Tumor Necrosis Factor-alpha, Interleukin-23, Protein Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Science and Engineering Research Board (SERB), National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificTumor Necrosis Factor-alphaInterleukin-23Protein EngineeringInflammationRecombinant Fusion ProteinsSerum Albumin, HumanHumansProtein DomainsPichia

Stichwörter der Autor:innen

Bispecific antibodyDomain antibodyIL-23InflammationPro-inflammatory cytokinesTNF-α

Substanzen

Antibodies, BispecificTumor Necrosis Factor-alphaInterleukin-23Recombinant Fusion ProteinsSerum Albumin, Human

Autor:innen und Institutionen

  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, India.
  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali, Punjab, 160062, India. apande@niper.ac.in.

Förderung

  • Science and Engineering Research Board (SERB)
  • National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar
  • Indian Council of Medical Research
  • Department of Biotechnology

Zitieren

APA

Sandeep, Shinde, S. H., Ahmed, S., Sharma, S. S., & Pande, A. H. (2026). Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy. Applied Biochemistry and Biotechnology, 198(7), 5212-5230. https://doi.org/10.1007/s12010-026-05702-0

Vancouver

Sandeep, Shinde SH, Ahmed S, Sharma SS, Pande AH. Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy. Applied Biochemistry and Biotechnology. 2026;198(7):5212-5230. doi:10.1007/s12010-026-05702-0

BibTeX
@article{Sandeep2026,
  author = {Sandeep and Shinde, Suraj H and Ahmed, Sakeel and Sharma, Shyam Sunder and Pande, Abhay H},
  title = {Engineering and Partial Characterization of an Anti-IL-23/Anti-TNF-α Bispecific Domain Antibody Fused to Human Serum Albumin Domain for Inflammatory Disease Therapy},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  volume = {198},
  number = {7},
  pages = {5212--5230},
  doi = {10.1007/s12010-026-05702-0}
}
Kostenlos starten →